WHO approves KFDA's ex post factor management for vaccine

Published: 2002-02-19 06:57:00

Updated: 2002-02-19 06:57:00

Korea Food and Drug Administration (KFDA) has announced it obtained an accreditation from World Health Organization (WHO) for license procedures and its ex post facto management involving vaccine preparations. This accreditation of WHO will pave the way for local vaccine makers to continuously ex...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK